山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
39期
23-26
,共4页
王艳萍%徐晓华%华颖%井淼
王豔萍%徐曉華%華穎%井淼
왕염평%서효화%화영%정묘
中枢神经系统感染%化脓性脑膜炎%病毒性脑炎%基质金属蛋白酶9%白细胞介素1%血-脑脊液屏障
中樞神經繫統感染%化膿性腦膜炎%病毒性腦炎%基質金屬蛋白酶9%白細胞介素1%血-腦脊液屏障
중추신경계통감염%화농성뇌막염%병독성뇌염%기질금속단백매9%백세포개소1%혈-뇌척액병장
central nervous system infection%purulent meningitis%viral encephalitis%matrix metalloproteinases 9%in-terleukin 1%blood-brain barrier
目的:观察中枢神经系统感染患儿血清、脑脊液基质金属蛋白酶9(MMP-9)和IL-1β水平变化,并探讨其意义。方法急性期中枢神经系统感染患儿50例,其中化脓性脑膜炎20例(化脑组)、病毒性脑炎30例(病脑组),非中枢神经系统感染患儿30例(对照组),采用ELISA法检测各组患儿血清及脑脊液MMP-9、IL-1β,全自动生化分析仪检测血清白蛋白(SAlb),免疫比浊法检测脑脊液白蛋白(CAlb),计算白蛋白指数(AQ)。结果化脑组、病脑组、对照组血清MMP-9水平分别为(489.98±159.09)、(267.85±91.89)、(133.03±31.64)μg/L,血清IL-1β水平分别为(21.35±4.91)、(19.57±5.70)、(14.07±3.94) ng/L,脑脊液MMP-9水平分别为(116.8±41.78)、(37.19±17.87)、(10.25±5.33)μg/L,脑脊液IL-1β水平分别为(106.28±12.83)、(66.95±10.63)、(49.97±12.57)ng/L,化脑组、病脑组分别与对照组比较,P均<0.01;化脑组与病脑组比较,P均<0.01(除血清IL-1β水平外)。化脑组、病脑组、对照组SAlb水平分别为(38.75±2.73)、(39.57±3.95)、(39.37±4.14) g/L,三组比较,P>0.01;CAlb水平分别为(1.04±0.28)、(0.54±0.14)、(0.18±0.08)g/L,AQ分别为26.97±7.29、13.76±3.45、4.61±2.05,化脑组、病脑组分别与对照组比较,P均<0.01;化脑组与病脑组比较,P均<0.01。化脑组、病脑组血清MMP-9、IL-1β水平呈正相关(r=0.304,P均<0.05),脑脊液MMP-9、IL-1β水平呈正相关(r=0.834,P<0.05)。结论中枢神经系统感染患儿血清、脑脊液MMP-9、IL-1β、CAlb水平升高,AQ增加,MMP-9、IL-1β可能参与了中枢神经系统感染血-脑脊液屏障功能损伤的病理过程。
目的:觀察中樞神經繫統感染患兒血清、腦脊液基質金屬蛋白酶9(MMP-9)和IL-1β水平變化,併探討其意義。方法急性期中樞神經繫統感染患兒50例,其中化膿性腦膜炎20例(化腦組)、病毒性腦炎30例(病腦組),非中樞神經繫統感染患兒30例(對照組),採用ELISA法檢測各組患兒血清及腦脊液MMP-9、IL-1β,全自動生化分析儀檢測血清白蛋白(SAlb),免疫比濁法檢測腦脊液白蛋白(CAlb),計算白蛋白指數(AQ)。結果化腦組、病腦組、對照組血清MMP-9水平分彆為(489.98±159.09)、(267.85±91.89)、(133.03±31.64)μg/L,血清IL-1β水平分彆為(21.35±4.91)、(19.57±5.70)、(14.07±3.94) ng/L,腦脊液MMP-9水平分彆為(116.8±41.78)、(37.19±17.87)、(10.25±5.33)μg/L,腦脊液IL-1β水平分彆為(106.28±12.83)、(66.95±10.63)、(49.97±12.57)ng/L,化腦組、病腦組分彆與對照組比較,P均<0.01;化腦組與病腦組比較,P均<0.01(除血清IL-1β水平外)。化腦組、病腦組、對照組SAlb水平分彆為(38.75±2.73)、(39.57±3.95)、(39.37±4.14) g/L,三組比較,P>0.01;CAlb水平分彆為(1.04±0.28)、(0.54±0.14)、(0.18±0.08)g/L,AQ分彆為26.97±7.29、13.76±3.45、4.61±2.05,化腦組、病腦組分彆與對照組比較,P均<0.01;化腦組與病腦組比較,P均<0.01。化腦組、病腦組血清MMP-9、IL-1β水平呈正相關(r=0.304,P均<0.05),腦脊液MMP-9、IL-1β水平呈正相關(r=0.834,P<0.05)。結論中樞神經繫統感染患兒血清、腦脊液MMP-9、IL-1β、CAlb水平升高,AQ增加,MMP-9、IL-1β可能參與瞭中樞神經繫統感染血-腦脊液屏障功能損傷的病理過程。
목적:관찰중추신경계통감염환인혈청、뇌척액기질금속단백매9(MMP-9)화IL-1β수평변화,병탐토기의의。방법급성기중추신경계통감염환인50례,기중화농성뇌막염20례(화뇌조)、병독성뇌염30례(병뇌조),비중추신경계통감염환인30례(대조조),채용ELISA법검측각조환인혈청급뇌척액MMP-9、IL-1β,전자동생화분석의검측혈청백단백(SAlb),면역비탁법검측뇌척액백단백(CAlb),계산백단백지수(AQ)。결과화뇌조、병뇌조、대조조혈청MMP-9수평분별위(489.98±159.09)、(267.85±91.89)、(133.03±31.64)μg/L,혈청IL-1β수평분별위(21.35±4.91)、(19.57±5.70)、(14.07±3.94) ng/L,뇌척액MMP-9수평분별위(116.8±41.78)、(37.19±17.87)、(10.25±5.33)μg/L,뇌척액IL-1β수평분별위(106.28±12.83)、(66.95±10.63)、(49.97±12.57)ng/L,화뇌조、병뇌조분별여대조조비교,P균<0.01;화뇌조여병뇌조비교,P균<0.01(제혈청IL-1β수평외)。화뇌조、병뇌조、대조조SAlb수평분별위(38.75±2.73)、(39.57±3.95)、(39.37±4.14) g/L,삼조비교,P>0.01;CAlb수평분별위(1.04±0.28)、(0.54±0.14)、(0.18±0.08)g/L,AQ분별위26.97±7.29、13.76±3.45、4.61±2.05,화뇌조、병뇌조분별여대조조비교,P균<0.01;화뇌조여병뇌조비교,P균<0.01。화뇌조、병뇌조혈청MMP-9、IL-1β수평정정상관(r=0.304,P균<0.05),뇌척액MMP-9、IL-1β수평정정상관(r=0.834,P<0.05)。결론중추신경계통감염환인혈청、뇌척액MMP-9、IL-1β、CAlb수평승고,AQ증가,MMP-9、IL-1β가능삼여료중추신경계통감염혈-뇌척액병장공능손상적병리과정。
Objective To explore the role of matrix metalloproteinases 9 ( MMP-9 ) and interleukin 1 in the central nervous system infection and investigate the significance.Methods The levels of MMP-9 and IL-1βin serum and cerebro-spinal fluid( CSF) of 20 purulent meningitis children( PM) , 30 viral encephalitis children( VE) , 30 acute non-central sys-tem infection children( control) were measured by ELISA.The level of serum albumin( SAlb ) was arrayed by automatic bio-chemical analyzer, and CSF albumin(CAlb) was detected by immunonephelometry to count AQ.Results The levels of MMP-9 in the serum of PM, VE and control were (489.98 ±159.09), (267.85 ±91.89) and (133.03 ±31.64)μg/L. The levels of IL-1βin serum of PM, VE and control were (21.35 ±4.91), (19.57 ±5.70) and (14.07 ±3.94)ng/L. The levels of MMP-9 in CSF of PM, VE and control were (116.8 ±41.78), (37.19 ±17.87) and (10.25 ±5.33)μg/L.The levels of IL-1βin CSF of PM, VE and control were (106.28 ±12.83), (66.95 ±10.63) and (49.97 ±12.57) ng/L.The levels of MMP-9, IL-1βin serum and CSF were significantly higher in PM and VE compared with the control(P<0.05).The levels of MMP-9, IL-1βalso showed significantly different between PM and VE(all P<0.05) except for IL-1βin serum.SAlb in PM, VE and control were (38.75 ±2.73), (39.57 ±3.95) and (39.37 ±4.14)g/L.There was no significant difference among the three groups(all P>0.05).CAlb in PM, VE and control were (1.04 ±0.28), (0.54 ±0.14) and (0.18 ±0.08)g/L.AQ were 26.97 ±7.29, 13.76 ±3.45 and 4.61 ±2.05.CAlb and AQ were significantly different among the three groups(P<0.05).There was a positive correlation between MMP-9 and IL-1βin serum(r=0.304, P<0.01) and CSF(r=0.834, P<0.01) in PM and VE.Conclusions The levels of MMP-9 and IL-1βin ser-um and CSF, CAlb and AQ increase in children with central nervous system infection.MMP-9 and IL-1βmay participate in the pathophysiologic course of blood-brain barrier impairment in the central nervous system infection.